Alere Determine HIV-1/2 Ag/Ab Combo Test Now Available

Alere Inc. has made available the Alere Determine HIV-1/2 Ag/Ab Combo test, the first rapid point-of-care test that detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, which can appear days after infection and prior to HIV-1/2 antibodies.

RELATED: Diagnostic Agents Resource Center

The Alere Determine HIV-1/2 Ag/Ab Combo test is a CLIA (Clinical Laboratory Improvement Amendments) moderately complex medical device that simultaneously detects free HIV-1 p24 antigen as well as both HIV-1 and HIV-2 antibodies in human serum, plasma, and venous or fingerstick whole blood specimens.

The test is currently undergoing CLIA-waiver studies to demonstrate its ease of use, safety and accuracy.

Alere Determine HIV-1/2 Ag/Ab Combo test is currently available to all health facilities and laboratories that are licensed to conduct tests of moderate complexity under the CLIA program.

For more information visit AlereHIV.com.

Loading links....